Effective Suppression of Human Immunodeficiency Virus Type 1 Through a Combination of Short- or Long-hairpin RNAs Targeting Essential Sequences for Retroviral Integration
Overview
Affiliations
Small interfering RNA (siRNA) could provide a new therapeutic approach to treating human immunodeficiency virus type 1 (HIV-1) infection. For long-term suppression of HIV-1, emergence of siRNA escape variants must be controlled. Here, we constructed lentiviral vectors encoding short-hairpin RNAs (shRNA) corresponding to conserved target sequences within the integrase (int) and the attachment site (att) genes, both of which are essential for HIV-1 integration. Compared to shRNA targeting of the HIV-1 transcription factor tat (shTat), shRNA against int (shIN) or the U3 region of att (shU3) showed a more potent inhibitory effect on HIV-1 replication in human CD4+ T cells. Infection with a high dose of HIV-1 resulted in the emergence of escape mutants during long-term culture. Of note, limited genetic variation was observed in the viruses resistant to shIN. A combination of shINs against wild-type and escape mutant sequences had a negative effect on their antiviral activities, indicating a potentially detrimental effect when administering multiple shRNA targeting the same region to combat HIV-1 variants. The combination of shIN and shU3 att exhibited the strongest anti-HIV-1 activity, as seen by complete abrogation of viral DNA synthesis and viral integration. In addition, a modified long-hairpin RNA spanning the 50 nucleotides in the shIN target region effectively suppressed wild-type and shIN-resistant mutant HIV-1. These results suggest that targeting of incoming viral RNA before proviral DNA formation occurs through the use of nonoverlapping multiple siRNAs is a potent approach to achieving sustained, efficient suppression of highly mutable viruses, such as HIV-1.
Chen X, Chen L, Chen B, Wei Q, Wu Y, Zhang Y Vet Sci. 2024; 11(10).
PMID: 39453043 PMC: 11511396. DOI: 10.3390/vetsci11100451.
Kang H, Ga Y, Kim S, Cho Y, Kim J, Kim C J Biomed Sci. 2023; 30(1):88.
PMID: 37845731 PMC: 10577957. DOI: 10.1186/s12929-023-00981-9.
Marshall J, Raban R, Kandul N, Edula J, Leon T, Akbari O Front Genet. 2019; 10:1072.
PMID: 31737050 PMC: 6831721. DOI: 10.3389/fgene.2019.01072.
Carbonell A, Lison P, Daros J Plant J. 2019; 100(4):720-737.
PMID: 31350772 PMC: 6899541. DOI: 10.1111/tpj.14466.
The therapeutic landscape of HIV-1 via genome editing.
Kwarteng A, Ahuno S, Kwakye-Nuako G AIDS Res Ther. 2017; 14(1):32.
PMID: 28705213 PMC: 5513397. DOI: 10.1186/s12981-017-0157-8.